HIV organisation to launch study on young women in southern Africa

The Botswana-Harvard AIDS Institute Partnership (BHP) said Monday that it is taking its HIV Prevention Trials Network studies to another level as it launches a new concept study that seeks to determine the effectiveness of passive infusion of antibodies in the prevention of HIV in young women in southern Africa.BHP is an organization that supports the country’s HIV/AIDS and public health research, education, prevention, and treatment services.

In a statement, BHP said the “the HPTN 081″ study also known as “antibody mediated protection “(AMP) is scheduled to start in the first quarter of 2016.

“This shall be conducted as part of a multi country and multi-site effort like the HIV Prevention Trials Network (HPTN) 052 study, locally referred to as the Thibelo study,” BHP said.

HIV Prevention Trials Network (HPTN) 052 study was a multi site multi country trial; a randomized trial to evaluate the effectiveness of antiretroviral therapy plus primary care compared to simply primary care on its own to prevent HIV sexual transmission among serodiscordant couples (couples where one partner is HIV positive and the other is not).

The study found that early anti retroviral therapy (ART) that suppresses viral replication led to 96% reduction of sexual transmission of HIV-1 in sero-discordant couples.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search